Cargando…

Ethical and social implications of using predictive modeling for Alzheimer’s disease prevention: a systematic literature review protocol

INTRODUCTION: The therapeutic paradigm in Alzheimer’s disease (AD) has shifted towards secondary prevention, defined as an intervention aiming to prevent or delay disease onset in pre-symptomatic individuals at risk of developing dementia due to AD. The key feature of AD prevention is the need to tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angehrn, Zuzanna, Nordon, Clementine, Turner, Andrew, Gove, Dianne, Karcher, Helene, Keenan, Alexander, Neumann, Monika, Sostar, Jelena, de Reydet de Vulpillieres, Frederic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443073/ https://www.ncbi.nlm.nih.gov/pubmed/30833325 http://dx.doi.org/10.1136/bmjopen-2018-026468

Ejemplares similares

Health Outcome Prioritization in Alzheimer’s Disease: Understanding the Ethical Landscape
por: McKeown, Alex, et al.
Publicado: (2020)

Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project
por: Gallacher, John, et al.
Publicado: (2019)

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
por: Brem, Anna-Katharine, et al.
Publicado: (2023)

Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
por: Vo, Pamela, et al.
Publicado: (2018)

Keeping track of and recognizing the value of Public Involvement work in dementia research
por: Georges, Jean, et al.
Publicado: (2022)

Testing the “RCT augmentation” methodology: A trial simulation study to guide the broadening of trials eligibility criteria and inform on effectiveness
por: Nordon, Clementine, et al.
Publicado: (2023)

The “RCT augmentation”: a novel simulation method to add patient heterogeneity into phase III trials
por: Karcher, Helene, et al.
Publicado: (2018)

New Ethical Issues in Cerebral Palsy
por: Dan, Bernard
Publicado: (2021)

Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China
por: Cao, Yuxia, et al.
Publicado: (2022)

Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias
por: Turner, R. Scott, et al.
Publicado: (2020)

The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease
por: de Lima, Izabella B.Q., et al.
Publicado: (2023)

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
por: Withington, Charles G., et al.
Publicado: (2022)

The ethical and validity conundrum in epilepsy research in LMIC settings
por: Samia, Pauline, et al.
Publicado: (2023)

Understanding living with tracheostomy ventilation for motor neuron disease and the implications for quality of life: a qualitative study protocol
por: Wilson, Eleanor, et al.
Publicado: (2023)

Chapter 12: Decompressive Craniectomy: Long Term Outcome and Ethical Considerations
por: Kwan, Kevin, et al.
Publicado: (2019)

CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One
por: Cretin, Benjamin, et al.
Publicado: (2021)

Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
por: Meier, Silvio R., et al.
Publicado: (2018)

Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
por: de Aquino, Camila Henriques
Publicado: (2021)

Ageing stereotypes and prodromal Alzheimer’s disease (AGING): study protocol for an ongoing randomised clinical study
por: Gauthier, Kim, et al.
Publicado: (2019)

Ethical Issues in Care and Treatment of Neuronal Ceroid Lipofuscinoses (NCL)–A Personal View
por: Kohlschütter, Alfried
Publicado: (2021)

Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
por: Gouilly, Dominique, et al.
Publicado: (2023)

New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol
por: Lanskey, Juliette Helene, et al.
Publicado: (2022)

Subjective Motives for Requesting In-Patient Treatment in Female with Anorexia Nervosa: A Qualitative Study
por: Gorse, Pauline, et al.
Publicado: (2013)

Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis
por: Schmidt, Elvira, et al.
Publicado: (2018)

Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer’s Disease
por: de Sousa, Natália Ferreira, et al.
Publicado: (2022)

Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis
por: Lulé, Dorothée, et al.
Publicado: (2019)

Alzheimer´s Disease in the Perspective of Neuroimmunology
por: Maccioni, Ricardo B., et al.
Publicado: (2018)

Tau Ubiquitination in Alzheimer's Disease
por: Li, Longfei, et al.
Publicado: (2022)

Networking of the Human Cerebellum: From Anatomo-Functional Development to Neurosurgical Implications
por: De Benedictis, Alessandro, et al.
Publicado: (2022)

Editorial: The Role of Glia in Alzheimer's Disease
por: Pérez-Nievas, Beatriz G., et al.
Publicado: (2019)

New Insights Into the Pathogenesis of Alzheimer's Disease
por: Fan, Liyuan, et al.
Publicado: (2020)

The Regulation of microRNAs in Alzheimer's Disease
por: Kou, Xianjuan, et al.
Publicado: (2020)

The Many Faces of Astrocytes in Alzheimer's Disease
por: Monterey, Michael D., et al.
Publicado: (2021)

Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2022)

Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management
por: Galvin, James E., et al.
Publicado: (2021)

Topology of diffusion changes in corpus callosum in Alzheimer's disease: An exploratory case-control study
por: Kumar, Sumeet, et al.
Publicado: (2022)

Corrigendum: Topology of diffusion changes in corpus callosum in Alzheimer's disease: An exploratory case-control study
por: Kumar, Sumeet, et al.
Publicado: (2023)

In vivo Imaging of Glial Activation in Alzheimer's Disease
por: Edison, Paul, et al.
Publicado: (2018)

Microglia in Alzheimer's Disease: Risk Factors and Inflammation
por: Katsumoto, Atsuko, et al.
Publicado: (2018)

Light-Induced Pupillary Responses in Alzheimer's Disease
por: Chougule, Pratik S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oej611oj2r32hlfm146nb7kjvj